IL252480B2

Heterodimeric antibodies that bind cd3 and tumor antigens

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority and filed
  2. Published
  3. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
WO2014047231A1CitesWorld Intellectual Property Organization (WIPO)YXSearch report1-36
WO2014145806A2CitesWorld Intellectual Property Organization (WIPO)YSearch report1-36
US2014294823A1CitesUnited States of AmericaYSearch report1-36
US2014302064A1CitesUnited States of AmericaYSearch report1-36
XENCOR, XENCOR PROVIDES DATA UPDATES ON XMAB BISPECIFIC ANTIBODY PROGRAMS AND ANNOUNCES PRESENTATIONS AT UPCOMING AMERICAN SOCIETY OF HEMATOLOGY 2014 ANNUAL MEETING, 6 November 2014 (2014-11-06)Non-patentSearch report
CHU, SEUNG Y., ET AL., IMMUNOTHERAPY WITH LONG-LIVED ANTI-CD20× ANTI-CD3 BISPECIFIC ANTIBODIES STIMULATES POTENT T CELL-MEDIATED KILLING OF HUMAN B CELL LINES AND OF CIRCULATING AND LYMPHOID B CELLS IN MONKEYS: A POTENTIAL THERAPY FOR B CELL LYMPHOMAS AND LEUKEMIAS., 4 December 2014 (2014-12-04)Non-patentSearch report